The 2-Minute Rule for conolidine
Elucidating the specific pharmacological mechanism of action (MOA) of Obviously developing compounds is often challenging. Even though Tarselli et al. (sixty) created the first de novo synthetic pathway to conolidine and showcased that this Normally taking place compound successfully suppresses responses to both chemically induced and inflammation-